Does Singulair Cause Hair Loss?
Hair loss is not listed as an adverse effect of Singulair (montelukast) in the FDA drug label, and based on the official prescribing information, there is no established causal relationship between montelukast and alopecia. 1
Evidence from FDA Drug Label
The FDA prescribing information for Singulair provides comprehensive adverse event data from both clinical trials and postmarketing surveillance. Hair loss (alopecia) is notably absent from both the clinical trial adverse events and the extensive postmarketing adverse reactions list. 1
The postmarketing section specifically catalogs adverse reactions by organ system, including detailed dermatological effects such as:
- Angioedema
- Bruising
- Erythema multiforme
- Erythema nodosum
- Pruritus
- Stevens-Johnson syndrome/toxic epidermal necrolysis
- Urticaria
Hair loss is not mentioned among these skin and subcutaneous tissue disorders. 1
Supporting Research Evidence
A 2025 real-world analysis of the FAERS database examining 86,732 montelukast reports identified 431 adverse event signals across 27 organ systems, but this study did not identify hair loss as a significant adverse drug reaction signal associated with montelukast. 2
Clinical Context
While many medications can cause drug-induced alopecia (particularly anticancer agents, interferon, azole antifungals, lithium, and immunosuppressants) 3, montelukast does not appear among the commonly implicated agents.
Clinical Recommendation
If a patient on Singulair presents with hair loss, investigate alternative causes rather than attributing it to the medication. Consider:
- Telogen effluvium from stress, illness, or other medications
- Androgenetic alopecia
- Alopecia areata
- Nutritional deficiencies
- Thyroid disorders
- Other concurrent medications
Discontinuing Singulair solely for hair loss concerns is not supported by the available evidence and may compromise asthma or allergic rhinitis control.